FIRAZYR 30 mg, solution injectable en seringue pré-remplie

Business Listing - September 04, 2021

FIRAZYR 30 mg, solution injectable en seringue pré-remplie

FIRAZYR 30 mg, solution injectable en seringue pré-remplie solution injectable sous-cutanée Autorisation active Procédure centralisée Commercialisée 7/11/2008 SHIRE HUMAN GENETIC THERAPIES (SUEDE)

Tags & Categories

active solution injectable autorisation procédure seringue cutanée centralisée remplie firazyr

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business